Clinical Trial Update: Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the tolerability and safety of AFFITOPE PD03A in patients with early Parkinson's disease has completed; the update summarizes safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AFFITOPE PD03A (PD03A)

Snippet

Sponsor: Affiris AG | Conditions: Parkinson Disease, Neurodegenerative Diseases | Phase 1 | Status: COMPLETED